Blocking the Metabolic Switch Toward Cytosolic 1C Flux: A Novel Therapeutic Approach for Tumors With Low SLC19A1 Expression
Main Authors: | Zhe Chen, Hong Zhou, Haoliang Hu, Linxi Chen |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2022-04-01
|
Series: | Pathology and Oncology Research |
Subjects: | |
Online Access: | https://www.por-journal.com/articles/10.3389/pore.2022.1610337/full |
Similar Items
-
SHMT2 Promotes Invasion and Migration of Breast Cancer Cells Through Binding to and Up-regulating HAX1
by: CHEN Qianzhi, et al.
Published: (2023-09-01) -
SHMT as a Potential Therapeutic Target for Renal Cell Carcinoma
by: Yongli Situ, et al.
Published: (2023-09-01) -
SHMT1 inhibits the metastasis of HCC by repressing NOX1-mediated ROS production
by: Changwei Dou, et al.
Published: (2019-02-01) -
The expression and clinical significance of serine hydroxymethyltransferase2 in gastric cancer
by: Yiming Shan, et al.
Published: (2024-01-01) -
SHMT2 expression as a diagnostic and prognostic marker for thyroid cancer
by: Meihua Jin, et al.
Published: (2021-06-01)